openPR Logo
Press release

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size, Shares, Business Growth and Upcoming Trends Forecast by 2033

06-11-2025 12:31 PM CET | Health & Medicine

Press release from: Orion Market Research

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market

The global Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta Isoform (PIK3CB) market was valued at approximately USD 140 million in 2023 and is projected to reach around USD 305 million by 2033, growing at a compound annual growth rate (CAGR) of approximately 8.1% from 2024 to 2033.

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Overview
The Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market growth is fueled by promising clinical trials and the development of PI3K-β inhibitors, such as GSK2636771 and BAY1082439, that specifically target the PIK3CB pathway. Pharmaceutical giants and biotech companies are increasingly investing in this niche, bolstered by advances in precision medicine and immunotherapy. Regulatory support and strategic partnerships are further enhancing commercialization potential. As understanding of the isoform's role in tumor progression deepens, the PIK3CB market is poised for substantial growth in the coming decade.

Request a sample copy of this report at: https://www.omrglobal.com/request-sample/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-beta-isoform-market

Advantages of requesting a Sample Copy of the Report:
1) To understand how our report can bring a difference to your business strategy
2) To understand the analysis and growth rate in your region
3) Graphical introduction of global as well as the regional analysis
4) Know the top key players in the market with their revenue analysis
5) SWOT analysis, PEST analysis, and Porter's five force analysis

The report further explores the key business players along with their in-depth profiling
Gilead, Novartis, Merck, Pfizer, AstraZeneca

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Segments:
◘ By Type: PI3K Inhibitors, Enzyme Modulators

◘ By Application: Oncology, Immunotherapy, Drug Development

Report Drivers & Trends Analysis:
The report also discusses the factors driving and restraining market growth, as well as their specific impact on demand over the forecast period. Also highlighted in this report are growth factors, developments, trends, challenges, limitations, and growth opportunities. This section highlights emerging Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market trends and changing dynamics. Furthermore, the study provides a forward-looking perspective on various factors that are expected to boost the market's overall growth.

Competitive Landscape Analysis:
In any market research analysis, the main field is competition. This section of the report provides a competitive scenario and portfolio of the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market's key players. Major and emerging market players are closely examined in terms of market share, gross margin, product portfolio, production, revenue, sales growth, and other significant factors. Furthermore, this information will assist players in studying critical strategies employed by market leaders in order to plan counterstrategies to gain a competitive advantage in the market.

Regional Outlook:
The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.
» North America (U.S., Canada, Mexico)
» Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
» Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
» South America (Brazil, Argentina, Rest of SA)
» Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

If you have any special requirements, Request customization: https://www.omrglobal.com/report-customization/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-beta-isoform-market

Key Benefits for Stakeholders:
⏩ The study represents a quantitative analysis of the present Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market trends, estimations, and dynamics of the market size from 2025 to 2032 to determine the most promising opportunities.
⏩ Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
⏩ In-depth analysis, as well as the market size and segmentation, help you identify current Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market opportunities.
⏩ The largest countries in each region are mapped according to their revenue contribution to the market.
⏩ The Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market research report gives a thorough analysis of the current status of the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market's major players.

Key questions answered in the report:
➧ What will the market development pace of the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market?
➧ What are the key factors driving the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market?
➧ Who are the key manufacturers in the market space?
➧ What are the market openings, market hazards,s and market outline of the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market?
➧ What are the sales, revenue, and price analysis of the top manufacturers of the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market?
➧ Who are the distributors, traders, and dealers of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market?
➧ What are the market opportunities and threats faced by the vendors in the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market?
➧ What are deals, income, and value examination by types and utilizations of the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market?
➧ What are deals, income, and value examination by areas of enterprises in the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market?

Purchase Now Up to 25% Discount on This Premium Report: https://www.omrglobal.com/buy-now/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-beta-isoform-market?license_type=license-single-user

Reasons To Buy The Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods

Contact Us:
Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Website: www.omrglobal.com
Follow Us: LinkedIn | Twitter

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size, Shares, Business Growth and Upcoming Trends Forecast by 2033 here

News-ID: 4061525 • Views:

More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Phosphatidylinositol

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Ma …
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market was valued at USD Billion in 2023 and is expected to grow at a CAGR of 27% between 2024 and 2031. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market research report is one of the effective ways to target customers and satisfy their growing needs as it gathers all the significant market data. It allows tracking future business
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Ma …
The global phosphatidylinositol 4,5 bisphosphate 3 kinase catalytic subunit beta isoform market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). This gene encodes an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K) and is important in signalling pathways that involve receptors on the outer membrane of eukaryotic cells. The major factor driving the market growth include the rising prevalence of cancer across the globe.
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Ma …
In 2018, the global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform. This report focuses on
Phosphatidylinositol 3-Kinase Inhibitors - Pipeline, Clinical Trials and Key Pla …
The PI3K inhibitors pipeline analysis report covers approximately 37 active drug candidates in different stages of development. Phosphatidylinositol 3-kinases (PI3K) are lipid kinases that are involved in cell regulation, including cell survival, proliferation and differentiation. They act as intermediate molecules in PI3K/AKT/mTOR signaling pathway by sending chemical messengers from cell surface to cytoplasm. These signals activate multiple effector kinase pathways, resulting in survival and growth of normal cells. Phosphatidylinositol 3-kinases is
Global Market Study On Phosphatidylinositol 4, 5 Bisphosphate 3 Kinase Catalytic …
Orbisreserach.Com Adds “H1 Phosphatidylinositol 4, 5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4, 5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2. 7. 1. 153) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Description: Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Phosphatidylinositol-4, 5-bisphosphate
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors Pipeline Analysis, 2017 by P&S M …
The PI3K inhibitors pipeline analysis report covers approximately 37 active drug candidates, of which eight drug candidates are in Phase III stage, 10 drug candidates are in Phase II stage, nine drug candidates Phase I stage, eight in Pre-Clinical stage and two drug candidates are in Discovery stage. Phosphatidylinositol 3-kinases (PI3K) are lipid kinases that are involved in cell regulation, including cell survival, proliferation and differentiation. They act as intermediate molecules